BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 15001156)

  • 1. Immunotherapy of melanoma: the good news, the bad ones and what to do next.
    Marincola FM; Ferrone S
    Semin Cancer Biol; 2003 Dec; 13(6):387-9. PubMed ID: 15001156
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy of melanoma.
    Parmiani G; Castelli C; Rivoltini L; Casati C; Tully GA; Novellino L; Patuzzo A; Tosi D; Anichini A; Santinami M
    Semin Cancer Biol; 2003 Dec; 13(6):391-400. PubMed ID: 15001157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells.
    Speiser DE; Pittet MJ; Rimoldi D; Guillaume P; Luescher IF; Liénard D; Lejeune F; Cerottini JC; Romero P
    Semin Cancer Biol; 2003 Dec; 13(6):461-72. PubMed ID: 15001165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine.
    Hsueh EC; Morton DL
    Semin Cancer Biol; 2003 Dec; 13(6):401-7. PubMed ID: 15001158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of clinical trials with an allogenic melanoma tumor cell lysate vaccine: Melacine.
    Sondak VK; Sosman JA
    Semin Cancer Biol; 2003 Dec; 13(6):409-15. PubMed ID: 15001159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of melanoma with an emphasis on immunotherapeutic strategies.
    Jack A; Boyes C; Aydin N; Alam K; Wallack M
    Surg Oncol; 2006 Jul; 15(1):13-24. PubMed ID: 16815006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of the eye and vision in a clinical trial of MART1-transformed dendritic cells for metastatic melanoma.
    Gordon LK; Ribas A; Nusinowitz S; Butterfield LH; Glaspy JA; Economou JS; Straatsma BR
    Control Clin Trials; 2004 Aug; 25(4):400-7. PubMed ID: 15296814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-recognition and tumor response to immunotherapy.
    Ernstoff MS
    J Clin Oncol; 2005 Sep; 23(25):5875-7. PubMed ID: 16087939
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunotherapy for melanoma: how can tolerance be overcome?].
    Robert C
    Ann Dermatol Venereol; 2001; 128(6-7):709-13. PubMed ID: 11460031
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy for malignant melanoma--tracing Ariadne's thread through the labyrinth.
    Grange JM; Krone B; Stanford JL
    Eur J Cancer; 2009 Sep; 45(13):2266-73. PubMed ID: 19497734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of immunotherapy in the treatment of melanoma.
    Faries MB
    Surg Oncol Clin N Am; 2006 Apr; 15(2):399-418. PubMed ID: 16632223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy of malignant melanoma--basic principles and novel therapeutic approaches].
    Enk AH; Becker JC; Schuler G
    J Dtsch Dermatol Ges; 2006 Aug; 4(8):635-45. PubMed ID: 16895565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of malignant melanoma.
    Kadison AS; Morton DL
    Surg Clin North Am; 2003 Apr; 83(2):343-70. PubMed ID: 12744613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination therapy of melanoma].
    Schuler-Thurner B; Schuler G
    J Dtsch Dermatol Ges; 2005 Aug; 3(8):630-45. PubMed ID: 16033483
    [No Abstract]   [Full Text] [Related]  

  • 15. The unfulfilled promise of melanoma vaccines.
    Livingston P
    Clin Cancer Res; 2001 Jul; 7(7):1837-8. PubMed ID: 11448892
    [No Abstract]   [Full Text] [Related]  

  • 16. Local delivery of poxvirus vaccines for melanoma.
    Hörig H; Kaufman HL
    Semin Cancer Biol; 2003 Dec; 13(6):417-22. PubMed ID: 15001160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New aspects of immunotherapy of malignant melanoma].
    Enk A
    Praxis (Bern 1994); 2001 Mar; 90(10):403-6. PubMed ID: 11305186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable melanoma vaccine enters human clinical trials.
    Nagda P
    Immunotherapy; 2013 Dec; 5(12):1277. PubMed ID: 24422231
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticytotoxic T lymphocyte-associated antigen 4 treatment--can melanoma be cured at the expense of autoimmune disorders?
    Lejeune FJ
    Melanoma Res; 2006 Oct; 16(5):377-8. PubMed ID: 17013085
    [No Abstract]   [Full Text] [Related]  

  • 20. Special report: vaccines for the treatment of malignant melanoma.
    Tecnologica MAP Suppl; 2001 Apr; ():19-20. PubMed ID: 11718143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.